Despite the widespread use of medicinal herbs to prevent and treat many diseases, including cancer, there are insufficient scientific data on the safety and efficacy of the majority of herbal therapies. The aim of this study was to assess the effect of a unique Chinese herbal therapy (CHT) from controlled manufactured concentrated powders, on an in vitro model of breast cancer. Three breast adenocarcinoma cell lines (MDA-231, MDA-453, T47D) were exposed to CHT for 72 h. Cell viability was assessed by XTT (sodium 3′-[1-(phenylaminocarbonyl)-3, 4-tetra zolium]-bis(4-methoxy-6-nitro) benzene sulphonic acid hydrate) assay. Apoptosis and cell cycle stage were determined by fluorescence-activated cell sorting (FACS) analysis. CHT decreased cell survival in a dose-dependent manner in all tested cell lines. FACS analysis of treated and non-treated T47D cells demonstrated that the inhibitory effect of CHT was associated with an increase in apoptosis. A randomized clinical trial is currently underway to investigate CHT as supplementary therapy for breast cancer patients receiving chemotherapy.
FerlayJShinHRBrayF: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer2010; epub ahead of print.
2.
JemalASiegelRWardE: Cancer statistics, 2007. CA Cancer J Clin2007; 57: 43–66.
3.
CraggGMNewmanDJ: Plants as a source of anti-cancer agents. J Ethnopharmacol2005; 100: 72–79.
4.
RichardsonMASandersTPalmerJL: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol2000; 18: 2505–2514.
5.
BernsteinBJGrassoT: Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Williston Park)2001; 15: 1267–1272.
6.
MolassiotisAScottJAKearneyN: Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer2006; 14: 260–267.
7.
BoonHWongJ: Botanical medicine and cancer: A review of the safety and efficacy. Expert Opin Pharmacother2004; 5: 2485–2501.
8.
CampbellMJHamiltonBShoemakerM: Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res2002; 22: 3843–3852.
9.
ShoemakerMHamiltonBDairkeeSH: In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res2005; 19: 649–651.
10.
ZhuKFukasawaIFurunoM: Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis. Gynecol Oncol2005; 97: 405–409.
11.
VexlerAMMouXGabizonAA: Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int J Cancer1995; 60: 611–615.
12.
GorodetskyRMouXPfefferMR: Subadditive effect of the combination of radiation and cisplatin in cultured murine and human cell lines. Isr J Med Sci1995; 31: 95–100.
13.
GorodetskyRLevy-AgababaFMouX: Combination of cisplatin and radiation in cell culture: Effect of duration of exposure to drug and timing of irradiation. Int J Cancer1998; 75: 635–642.
14.
ZhangMChiuLCCheungPC: Growth-inhibitory effects of a β-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction. Oncol Rep2006; 15: 637–643.
15.
ZhangHYGeNZhangZY: Theoretical elucidation of activity differences of five phenolic antioxidants. Zhongguo Yao Li Xue Bao1999; 20: 363–366.
16.
NizamutdinovaITOhHMMinYN: Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-α-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-κB signaling pathways. Int Immunopharmacol2007; 7: 343–350.
17.
KarinM: Nuclear factor-κB in cancer development and progression. Nature2006; 441: 431–436.
TianQMillerEGAhmadH: Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer2001; 40: 180–184.
20.
MantheyJAGuthrieN: Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem2002; 50: 5837–5843.
21.
KangSAParkHJKimMJ: Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J Ethnopharmacol2005; 97: 231–235.
22.
GuptaSZhangDYiJ: Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother2004; 4: 21–33.
23.
YoshidaYWangMQLiuJN: Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol1997; 19: 359–370.
24.
WongBYLauBHJiaTY: Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer Biother Radiopharm1996; 11: 51–56.
25.
YinXZhouJJieC: Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci2004; 75: 2233–2244.
26.
YaoHLiSHuJ: Chromatographic fingerprint and quantitative analysis of seven bioactive compounds of Scutellaria barbata. Planta Med2010; epub ahead of print.
27.
RugoHShtivelmanEPerezA: Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat2007; 105: 17–28.
28.
LiuFXieZHCaiGP: The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull2007; 30: 2279–2283.
29.
MeslinFHamaïAGaoP: Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res2007; 67: 10910–10919.
